BioSpace Promotes the Northeast Corridor's Life Science Industry

Print and online campaign profiles one of the nation's most urbanized regions

DENVER, June 30, 2011 /PRNewswire/ -- Today BioSpace, the leading life sciences employment and news Web site, launched the 2011-2012 Pharm Country™ Hotbed Campaign, marking the campaigns 10th edition.

(Logo: http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO )

The campaign highlights companies from Niagara Falls to Atlantic City. Logos for participating companies are included on an electronic and print map promoting members both online as well as at industry events and career fairs.

"Our nine annual Hotbed campaigns represent a one-of-a-kind opportunity for industry businesses to showcase their brand, location and place within the industry," said Mike Tansey, chief executive officer at onTargetjobs, the parent company of BioSpace.

PharmCountry is part of a series of Hotbed campaigns that are each hosted on their own BioSpace Web page. The campaign's participating companies include Pfizer, ViroPharma Incorporated, Laureate Biopharmaceutical Services, Inc., Purdue Pharma, and more.

About BioSpace.com

BioSpace.com is the leading, online resource for industry careers, news and resources. For 25 years, BioSpace has helped accelerate recruitment, communication and discovery among business and scientific leaders within the life sciences.

An onTargetjobs, Inc., company, BioSpace powers DeviceSpace.com, an information and recruitment resource for the medical device and diagnostics industries, as well as ClinicaSpace.com, a similar resource for clinical research markets.

SOURCE BioSpace

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.